NS3/4A Protease Inhibitors

All categories
DBCAT002768Therapeutic category

Inhibitors of the NS3/4A serine protease of Hepatitis C Virus (HCV). A DrugBank category of 7 drugs. 7 of them are approved.

Also known as
Hepatitis C Virus NS3/4A Protease Inhibitor
Drugs

What you can answer from here — as of March 17, 2020

7DrugsEach linked to its full drug card
Listed above
6Drug targetsEvery drug–target pair in the class, with bond type
Sign in
60Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do NS3/4A Protease Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In